The Research Partnership in Cognitive Aging, a public-private effort to promote the study of brain function with age, will award up to $28 million over five years to 17 research grants to examine the neural and behavioral profiles of healthy cognitive aging and explore interventions that may prevent, reduce or reverse cognitive decline in older people.
A simple and cheap way of making vaccines stable — even at tropical temperatures — has been developed by scientists at Oxford University and Nova Bio-Pharma Technologies. The British technology has the potential to revolutionise vaccination efforts, particularly in the developing world where infectious diseases kill millions of people every year, by removing the need for fridges, freezers and associated health infrastructure.
Together with the Fogarty International Center (FIC), part of the National Institutes of Health, and funded by the Bill & Melinda Gates Foundation, researchers will study the linkages of malnutrition and intestinal infections and how they affect children in the developing world.
The use of adiponectin, a hormone derived from fat cells, which is abundant in plasma and easy to measure through commercially available kits, was confirmed as a robust biomarker predictive of glycemic efficacy in Type 2 diabetes and healthy subjects, after treatment with peroxisome proliferator-activated receptor-agonists (PPAR), but not after treatment with non-PPAR drugs such as metformin.
The 2009 mHealth (Mobile Health) Summit, organized by the Foundation for the National Institutes of Health (FNIH), today opens an unprecedented two-day summit bringing together more than 800 public and private sector science, medical, policy and mobile technology experts to develop a new roadmap related to the integration of science and wireless solutions to improve public health delivery, particularly to underserved populations, in the U.S. and around theworld.
he Boo! Run for Life 10K today announced that it has teamed up with anchor and managing editor of E! News Giuliana Rancic, and television host, speaker, and entrepreneur Bill Rancic in support of renal cell (or kidney) cancer research.
Today, the Foundation for the National Institutes of Health and sanofi-aventis announced an unprecedented donation by the global pharmaceutical leader providing approximately $1.3 million in pharmaceutical therapies for ongoing use in clinical trials and other therapeutic treatments at the National Institutes of Health (NIH)